R. Michael Carruthers - 11 Oct 2024 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Chief Financial Officer
Signature
/s/ John R. Moore Attorney-in-Fact for R. Michael Carruthers
Issuer symbol
EWTX
Transactions as of
11 Oct 2024
Transactions value $
$49,700
Form type
4
Filing time
16 Oct 2024, 16:23:23 UTC
Previous filing
08 Oct 2024
Next filing
07 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EWTX Common Stock Options Exercise $49.7K +70K +1013.9% $0.71 76.9K 11 Oct 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Option (Right to Buy) Options Exercise $0 -70K -35.51% $0.00 127K 11 Oct 2024 Common Stock 70K $0.71 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.